Changement de paradigme dans les thérapies ciblant les protéines membranaires - De la production d'antigènes à la validation des candidats - IPBS-Toulouse, Seminar Room
Le
A 08h30
IPBS-Toulouse, Seminar Room
Entrée gratuite mais sur inscription
08:30 Registration and Participants welcome
09:00 Changing paradigm on membrane proteins as target for antibody discovery and validation: Case study | Dr. Rosie Dawaliby (CEO, G.CLIPS biotech)
10:00 Writing the future of biologics with an integrated offering of immunization, libraries, and machine learning | Dr. Radha Parmar (Twist Bioscience)
11:00 Coffee Break
11:15 The DNA engine that powers the bio-economy | Dr. Radha Parmar (Twist Bioscience)
11:35 Quality control and characterization of mAbs and ADCs by structural mass spectrometry | Dr. Julien Marcoux (IPBS)
12:05 Innovative biophysical methods for the characterization of macromolecules such as antibodies and ADCs conjugates | Dr. Virginie Nahoum (Head of PICT, Toulouse Integrated Screening Platform)
12:35 Closing remarks by Conference chair
IPBS-Toulouse, Seminar Room Les prochaines sorties
Dr. Hung Le - Hunt to eat: metabolic reprogramming drives the dynamics of interbacterial predation
Dr. Thomas Marichal - Regulation of monocyte-to-macrophage trajectories in the healthy and diseased lung
Dr. Rasmus Mortensen - A next-generation TB vaccine designed for induction of Th17 cells and synergy with BCG
Événements similaires
Constanţa, au-delà des frontières 4
0 Commentaire Soyez le premier à réagir